SGMT SCHEDULE 13G: SEC filing
SilverArc Capital Management, LLC
Filed with the SEC on · accession 0001104659-26-127339
SGMT filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -6.5% by the first close after the filing.
Summary of the filing
SilverArc Capital Management, LLC filed a Schedule 13G disclosing beneficial ownership of 3,745,990 shares, or 6.1%, of Sagimet Biosciences Inc. Class A Common Stock as of September 30, 2026, as an investment adviser to various clients.
Key details
How SGMT stock reacted
Close before
$10.93
Nov 12, 2026
First close after
-6.50%
$10.22
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SGMT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SGMT?
Click hereFrequently asked questions
What did SGMT file with the SEC on Nov 13, 2026?
SGMT filed a SCHEDULE 13G (SEC filing). SilverArc Capital Management, LLC filed a Schedule 13G disclosing beneficial ownership of 3,745,990 shares, or 6.1%, of Sagimet Biosciences Inc. Class A Common Stock as of September 30, 2026, as an investment adviser to various clients.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did SGMT stock react to this filing?
SGMT closed at $10.93 before the filing and $10.22 on Nov 13, 2026 (-6.50%).
Other SGMT SEC filings
- 10-Q · SEC filingNov 12, 2026
- 8-K · SEC filingNov 12, 2026
- 8-K · SEC filingOct 22, 2026
- SCHEDULE 13G · SEC filingOct 7, 2026
- 8-K · Secondary offeringOct 1, 2026
- 8-K · Fda approvalSep 30, 2026
- 424B3 · Secondary offeringSep 30, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
- 8-K · Fda approvalAug 13, 2026
- 10-Q · SEC filingAug 11, 2026
Get alerts when SGMT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days